Disturbed estrogen and progesterone action in ovarian endometriosis

Molecular and Cellular Endocrinology

Volumn 301, Issue 1-2, 2009, Pages 59-64

  Šmuc, Tina ^a   Hevir, Neli ^a   Ribič Pucelj, Martina ^b   Husen, Bettina ^c   Thole, Hubert ^c   Rižner, Tea Lanišnik ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^c Solvay Pharmaceuticals GmbH   (Germany)

Author keywords

17 Hydroxysteroid dehydrogenases; AKR1C1; AKR1C3; Endometriosis; Estrogen and progesterone receptors; Estrogen and progesterone metabolizing enzymes

Indexed keywords

ALDEHYDE KETONE REDUCTASE; AROMATASE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; OXIDOREDUCTASE; PROGESTERONE; PROGESTERONE RECEPTOR; SULFATASE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ESTROGEN METABOLISM; FEMALE; HORMONE METABOLISM; HUMAN; OVARY; PRIORITY JOURNAL; PROGESTERONE METABOLISM; PROTEIN EXPRESSION; UPREGULATION;

17-HYDROXYSTEROID DEHYDROGENASES; 20-HYDROXYSTEROID DEHYDROGENASES; 3-HYDROXYSTEROID DEHYDROGENASES; ADULT; AROMATASE; ENDOMETRIOSIS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARY; PROGESTERONE; RECEPTORS, PROGESTERONE; SULFOTRANSFERASES;

EID: 60249095065     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.07.020     Document Type: Article

References (33)

1. Amsterdam L.L., Gentry W., Jobanputra S., Wolf M., Rubin S.D., and Bulun S.E. Anastrazole and oral contraceptives: a novel treatment for endometriosis. Fertil. Steril. 84 (2005) 300-304
2. Attia G.R., Zeitoun K., Edwards D., Johns A., Carr B.R., and Bulun S.E. Progesterone receptor isoform A but not B is expresses in endometriosis. Clin. End. Metab. 85 (2000) 2897-2902
3. Berkley K.J., Rapkin A.J., and Papka R.E. The pains of endometriosis. Science 308 (2005) 1587-1589
4. Bukulmez O., Hardy D.B., Carr B.R., Word R.A., and Mendelson C.R. Inflammatory status influences aromatase and steroid expression in endometriosis. Endocrinology 149 (2008) 1190-1204
5. Bulun S.E., Zeitoun K., Takayama K., Noble L., Michael D., Simpson E., Johns A., Putman M., and Sasano H. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr. Relat. Cancer 6 (1999) 293-301
6. Bulun S.E., Zeitoun K., Takayama K., and Sasano H. Estrogen biosynthesis in endometriosis: molecular basis and clinical relevance. J. Mol. Endocrinol. 25 (2000) 35-42
7. Bulun S.E., Yang S., Fang Z., Gurates B., Tamura M., Zhou J., and Sebastian S. Role of aromatase in endometrial disease. J. Steroid Biochem. Mol. Biol. 79 (2001) 19-25
8. Bulun S.E., Imir G., Utsunomiya H., Thung S., Gurates B., Tamura M., and Lin Z. Aromatase in endometriosis and uterine leiomyomata. J. Steroid Biochem. Mol. Biol. 95 (2005) 57-62
9. Dassen H., Pundayeera C., Kamps R., Delvoux B., Van Langendonckt A., Donnez J., Husen B., Thole H., Dunselman G., and Groothuis P. Estrogen metabolizing enzymes in endometrium and endometriosis. Hum. Reprod. 22 (2007) 3148-3158
10. Grümmer R. Animal models in endometriosis research. Hum. Reprod. Update 12 (2006) 641-649
11. Fujimoto J., Hirose R., Sakaguchy H., and Tamaya X. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Mol. Hum. Reprod. 5 (1999) 742-747
12. Hudelist G., Czerwenka K., Keckstein J., Haas C., Fink-Retter A., Gscwantler-Kautlic D., Kubista E., and Siger C.F. Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod. Sci. 14 (2007) 798-805
13. Labrie F., Luu-The V., Lin S.X., Simard J., Labrie C., El-Alfy M., Pelletier G., and Bélanger A. Intracrinology: role of the family of 17β-hydroxysteroid dehydrogenases in human physiology and disease. J. Mol. Endocrinol. 25 (2000) 1-16
14. Luu-The V. Analysis and characteristics of multiple types of human 17β-hydroxysteroid dehydrogenase. J. Steroid Biochem. Mol. Biol. 76 (2001) 143-151
15. Luu-The V., Tremplay P., and Labrie F. Characterisation of type 12 17β-hydroxysteroid dehydrogenase, an isoform of type 3 17β-hydroxysteroid dehydrogenase responsible for estradiol formation in women. Mol. Endocrinol. 20 (2006) 437-443
16. Matsuzaki S., Muramaki T., Uehara S., Canis M., Sasano H., and Okamura K. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertil. Steril. 75 (2001) 1198-1205
17. Matsuzaki S., Canis M., Pouly J.L., Botchorishvili R., Déchelotte P.J., and Mage G. Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis. Fertil. Steril. 86 (2006) 548-553
18. Midnich R., Möller G., and Adamski J. The role of 17 beta-hydroxysteroid dehydrogenases. Mol. Cell Endocrinol. 218 (2004) 7-20
19. Misao R., Iwagaki S., Fujimoto J., Sun W.S., and Tamaya T. Dominant expression of progesterone receptor form B mRNA in ovarian endometriosis. Horm. Res. 52 (1999) 30-34
20. Noble L.S., Simpson E.R., Johns A., and Bulun S.E. Aromatase expression in endometriosis. J. Clin. Endocrinol. Metab. 81 (1996) 174-179
21. Nap A.W., Groothuis P.G., Demir A.Y., Evers J.L.H., and Dunselman G.A.J. Pathogenesis of endometriosis. Best Pract. Res. Clin. Obstet. Gynaecol. 18 (2004) 233-244
22. Olive D.L., and Schwartz L.B. Endometriosis. N. Engl. J. Med. 328 (1993) 1759-1769
23. Oehler M.K., Rees C.P.R., and Bickner R. Steroids and the endometrium. Curr. Med. Chem. 7 (2000) 543-560
24. Pollow K., Lübbert H., Boquoi E., and Pollow B. Progesterone metabolism in normal human endometrium during the menstrual cycle and in endometrial carcinoma. J. Clin. Endocrinol. Metab. 41 (1975) 729-737
25. Patwardhan S., Nawathe A., Yates D., Harrison G.R., and Khan K.S. Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis. BJOG 115 (2008) 818-822
26. Pearce S.T., and Jordan V.C. The biological role of estrogen receptors α and β. Crit. Rev. Oncol. Hematol. 50 (2004) 3-22
27. Penning T.M., Burczynski M.E., Jez J.M., Hung C.F., Lin H.K., Ma H., Moore M., Palackal N., and Ratnam K. Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of aldo-keto reductase family: functional plasticity and tissue distributions reveals roles in the inactivation and formation of male and female sex hormones. Biochem. J. 351 (2000) 67-77
28. Penning T.M. Hydroxysteroid dehydrogenases and pre-receptor regulation of steroid hormone action. Hum. Reprod. Update 9 (2003) 193-205
29. Šmuc T., Kristan K., Bajc G., Šinkovec J., Ribič-Pucelj M., Husen B., Thole H., and Lanišnik Rižner T. Are 17beta-HSDs responsible for increased estradiol concentrations within ectopic and cancerous endometrium?. In: Weiner H., Maser E., Lindahl R., and Plapp B. (Eds). Enzymology and Molecular Biology of Carbonyl Metabolism vol. 13 (2007), Purdue University, Purdue 350-359
30. Šmuc T., Ribič-Pucelj M., Šinkovec J., Husen B., Thole H., and Lanišnik Rižner T. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecol. Endocrinol. 23 (2007) 105-111
31. Vegeto E., Shahbaz M.M., Wen D.X., Goldman M.E., O'Malley B.W., and McDonnell D.P. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol. Endocrinol. 7 (1993) 1244-1255
32. Vikho P., Härkönen P., Soronen P., Törn S., Herrala A., Kurkela R., Pulkka A., Oduwole O., and Isomaa V. 17β-Hydroxysteroid dehydrogenases-their role in pathophysiology. Mol. Cell Endocrinol. 215 (2004) 83-88
33. Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., and Andersson S. Deficient 17β-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17β-estradiol. J. Clin. Endocrinol. Metab. 83 (1998) 4474-4480